Amsterdam’s Healthplus.ai has raised €2.3M to develop further and expand its AI technology, designed to support hospitals in managing surgical care.
On June 1, 2015, Schumacher arrived at St. Charles Hospital’s emergency department by ambulance and was admitted for ...
Studying T cells, the immune cells most responsible for responding to infections and cancers, just received a significant ...
7d
NanoViricides, Inc. Has Filed its Quarterly Report – Subsequent Raise Has Fortified Fiscal Position
SHELTON, CONNECTICUT / ACCESS Newswire / November 17, 2025 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the “Company”), reports that it has filed its Quarterly Report on Form 10-Q for the fiscal quarter ...
Freiburg forward Cyriaque Irié continues to improve after his malaria infection, coach Julian Schuster said on Thursday, but ...
It’s 2025, yet the word “vagina” still makes many people uncomfortable. Say it in a room full of adults, and you’ll get nervous laughs. Post it online, and ...
SHELTON, CONNECTICUT / ACCESS Newswire / October 15, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), reports that an analyst research report was published on the Company that explains ...
Broad-spectrum Antiviral NV-387 At Phase II Clinical Trial Stage – NV-387 Could Become a Revolutionary Antiviral for Respiratory Viral Infections SHELTON, CONNECTICUT / ACCESS Newswire / September 30, ...
Oral NV-387 was found to cure lethal lung RSV infection in an animal model. There is no current approved drug for treating RSV infection. Previously, NV-387 given both orally and as I.V. injections ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback